We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Abbott Diagnostics- Hematology Division

CERTEST BIOTEC

Certest Biotec, S.L. develops and manufactures IVD products in the human clinical testing field, including rapid test... read more Featured Products: More products

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Certest Offers Real-Time PCR Assays for Fast Detection of MDR Bacterial Infections

By LabMedica International staff writers
Posted on 23 Sep 2021
Print article

CerTest Biotec (Zaragoza, Spain) has joined the fight against multidrug resistant strains (MDR) bacterial infections by developing real-time PCR assays for the fast detection of genes or punctual mutations that confer resistance to antibiotics from both Gram-positive and Gram-negative pathogens.

Resistance to antibiotics is a natural phenomenon, through which bacteria are able to adapt and survive the activity of these compounds and poses a serious global threat of growing concern to human, animal, and environment health. This is due to the emergence, spread, and persistence of the “superbugs.” Multidrug bacteria exist across the animal, human, and environment triangle and there is interlinked sharing of these pathogens in this triad. The plausible causes of the AMR include excessive use of antibiotics in animals and humans, antibiotics sold over-the-counter, poor sanitation, and release of non-metabolized antibiotics or their residues into the environment through manure. These factors contribute to genetic selection pressure for the emergence of MDR bacterial infections in the community.

Initial inappropriate antimicrobial therapy of severe infections leads to an increased morbidity and mortality. Adequate therapy of severe infections caused by MDR is challenging as many of the main compounds typically used for infections caused by susceptible microorganisms are inactive. This may lead to extensive use of broad-spectrum antibiotics, which would contribute to selection of further resistance and may also expose patients to unnecessary toxicity.

Routine antibiogram techniques are based on a phenotypic study in which microbial growth is observed in the presence of different antibiotics. These techniques include broth macrodilution and microdilution (the gold standard for the antibiogram), agar dilution and strips with an antibiotic gradient. They yield results in around 17 hours. This is why alternative techniques to conventional diagnosis are required that present greater speed, sensitivity, specificity and ability to detect microorganisms, along with their antibiotic resistance mechanism. In addition, techniques are sought with the highest degree of automation possible, ease of implementation and a good cost effectiveness ratio.

CerTest has developed real-time PCR assays for the fast detection of genes or punctual mutations that confer resistance to antibiotics from both Gram-positive and Gram-negative pathogens. These products include multiplex assays for the detection of the principal carbapenem-resistance genes, Methicillin-resistant Staphylococcus aureus infections (MRSA), vancomycin-resistant enterococci (VRE), and the principal beta-lactamase genes. These four multiplex assays cover the main antibiotic resistance genes associated with MDR bacterial infections and sepsis-causing pathogens.

The advantage of these multiplex products is that they can each be used individually or as a broad-spectrum panel to evaluate a sample from a patient. They have been validated both in swab specimens and direct-from-blood. This clinical diagnostic tool allows obtaining the results without having to wait for the incubation time of a culture and has proven to be more sensitive and accurate than these traditional techniques, being able to initiate a personalized treatment, offering a structural model for efficient health care and avoiding the massive use of antibiotics.

Related Links:

CerTest Biotec

Gold Supplier
SARS-CoV-2/Flu A/B & RSV Test
RespiBio Panel 3 (RBRP3)
New
Bench-Top Molecular Microarray System
NanoCHIP XL Analyzer
New
6-Channel Viscoelastometry Analyzer
ClotPro
New
Silver Supplier
Bacteriuria Test Strips
MAST Bacteruritest Strips

Print article

Channels

Molecular Diagnostics

view channel
Image: Absence of nuclear immunohistochemical staining of MSH2 protein (A) and presence of MLH1 protein (B) in urothelial cell carcinoma of the urinary bladder of a patient carrying a germline MSH2 mutation. Observe the nuclear staining in stromal cells as an internal control (Photo courtesy of Radboud University Nijmegen Medical Centre)

Simple Urine Test Detects Urothelial Cancers in Lynch Syndrome Patients

Lynch Syndrome (LS) is an inherited genetic disorder that carries a high risk of cancer. LS is caused by mutations affecting MLH1, MSH2, MSH6 or PMS2 genes. More than one in 300 people have LS but most... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test for screening, diagnosis and management of sickle cell disease and related hemoglobinopathies at the point of care (Photo courtesy of Hemex Health)

Point-of-Care Device Accurately Rapidly Diagnoses Sickle Cell Disease

Hemoglobinopathies are the most common autosomal hereditary disorders. Approximately 7% of the global population carries hemoglobin gene mutation including structural hemoglobin variants like sickle hemoglobin... Read more

Immunology

view channel
Image: The IMMULITE 2000 XPi Immunoassay System provides multiple tests on a single, easy-to-use analyzer, including the thyroid-stimulating immunoglobulin assay (Photo courtesy of Siemens Healthcare)

Immunoassays Evaluated for Thyroid-Stimulating Receptor Antibody in Graves’ Disease

Graves' disease (GD), also known as toxic diffuse goiter, is an autoimmune disease that affects the thyroid. It frequently results in and is the most common cause of hyperthyroidism and it also often results... Read more

Microbiology

view channel
Image: The sciREADER CL2 enables high quality digital colorimetric imaging of various support formats (Photo courtesy of SCIENION)

Multiplex Immunoassay Developed for Confirmation and Typing of HTLV Infections

Human T-Cell Lymphotropic Viruses (HTLV) type 1 and type 2 account for an estimated five to 10 million infections worldwide and are transmitted through breast feeding, sexual contacts and contaminated... Read more

Technology

view channel
Image: PKeye Workflow Monitor System (Photo courtesy of PerkinElmer, Inc.)

PerkinElmer’s New Cloud-Based Platform Enables Laboratory Personnel to Remotely Manage Its Instruments in Real-Time

PerkinElmer, Inc. (Waltham, MA; USA) has launched its PKeye Workflow Monitor, a cloud-based platform enabling laboratory personnel to remotely manage and monitor their PerkinElmer instruments and workflows... Read more

Industry

view channel
Illustration

Global Point of Care Diagnostics Market to Top USD 35 Billion by 2027 Due to Rising Diabetic Cases

The global point of care diagnostics market is projected to grow at a CAGR of close to 6% from more than USD 23 billion in 2020 to over USD 35 billion by 2027, driven by an increase in the number of diabetic... Read more
Copyright © 2000-2021 Globetech Media. All rights reserved.